UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 973

Sortiert nach

Frequency of safety net errors in the emergency department: Effect of patient handoffs

The American journal of emergency medicine, 2021-04, Vol.42, p.188-191

2021

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults

Antimicrobial Agents and Chemotherapy, 2003-09, Vol.47 (9), p.2788-2795

2003

Volltextzugriff (PDF)

Evaluation of Commercial Milk-Specific Lateral Flow Devices

Journal of food protection, 2016-10, Vol.79 (10), p.1767-1774

2016

Volltextzugriff (PDF)

Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2004-09, Vol.48 (9), p.3543-3551

2004

Volltextzugriff (PDF)

Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study

The Lancet. Haematology, 2015-08, Vol.2 (8), p.e339-e346

2015

Volltextzugriff (PDF)

Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men

Antimicrobial Agents and Chemotherapy, 2004-03, Vol.48 (3), p.804-808

2004

Volltextzugriff (PDF)

A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension

Current eye research, 2011-09, Vol.36 (9), p.809-817

2011

Volltextzugriff (PDF)

Latanoprost Systemic Exposure in Pediatric and Adult Patients with Glaucoma: A Phase 1, Open-Label Study

Ophthalmology (Rochester, Minn.), 2011-10, Vol.118 (10), p.2022-2027

2011

Volltextzugriff (PDF)

Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer

Clinical cancer research, 2012-01, Vol.18 (2), p.568-576

2012

Volltextzugriff (PDF)

New Paths and Policies towards Conflict Prevention: Chinese and Swiss Perspectives

1, 2021

Volltextzugriff (PDF)

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

Blood, 2012-05, Vol.119 (20), p.4597-4607

2012

Volltextzugriff (PDF)

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

British journal of clinical pharmacology, 2004-02, Vol.57 (2), p.218-222

2004

Volltextzugriff (PDF)

A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumors

Clinical cancer research, 2015-03, Vol.21 (5), p.1044-1051

2015

Volltextzugriff (PDF)

Oral bioavailability of posaconazole in fasted healthy subjects: Comparison between three regimens and basis for clinical dosage recommendations

Clinical pharmacokinetics, 2005-01, Vol.44 (2), p.211-220

2005

Volltextzugriff (PDF)

What Is in My Patient's Pantry? Addressing Food Insecurity in Primary Care: A Quality Improvement Project

Koontz, Rachel Courtney

2021

Volltextzugriff (PDF)

Estrogens, Inflammation, and Cognition: Does Inflammation Mediate Verbal Memory Deficits Observed in Surgically Menopausal Women?

Kannampuzha, Courtney Rachel

2020

Volltextzugriff (PDF)

Modulation of 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11βHSD1 Inhibitor

The journal of clinical endocrinology and metabolism, 2008-02, Vol.93 (2), p.550-556

2008

Volltextzugriff (PDF)

Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity in Vivo Limits Glucocorticoid Exposure to Human Adipose Tissue and Decreases Lipolysis

The journal of clinical endocrinology and metabolism, 2007-03, Vol.92 (3), p.857-864

2007

Volltextzugriff (PDF)

Novel homozygous likely-pathogenic intronic variant in INS causing permanent neonatal diabetes in siblings

Journal of pediatric endocrinology & metabolism : JPEM, 2016-09, Vol.29 (9), p.1089

2016

Volltextzugriff (PDF)

Structural Evolution and Rheology of the Paposo Shear Zone in the Atacama Fault System, Northern Chile

Ruthven, Rachel Courtney

2018

Volltextzugriff (PDF)

AN EYE FOR AN EYE LEAVES EVERYONE BLIND: FIELDS V. BROWN AND THE CASE FOR KEEPING THE BIBLE OUT OF CAPITAL SENTENCING DELIBERATIONS

Northwestern University law review, 2009, Vol.103 (1), p.369

Baron, Courtney Rachel

2009

Volltextzugriff (PDF)

Phase 1 Dose-Escalation Study of PF-04449913, An Oral Hedgehog (Hh) Inhibitor, in Patients with Select Hematologic Malignancies

Blood, 2011-11, Vol.118 (21), p.424-424

2011

Volltextzugriff (PDF)

Abstract 4619: PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4619-4619

2012

Volltextzugriff (PDF)

Abstract 906: Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.906-906

2012

Volltextzugriff (PDF)

Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor

The journal of clinical endocrinology and metabolism, 2008-02, Vol.93 (2), p.550

2008

Volltextzugriff (PDF)

1 – 25 von 973

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(876)
Mit Volltextzugriff
(888)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(569)
Life Sciences & Biomedicine
(516)
Humans
(371)
Female
(221)
Male
(187)
Adult
(123)
Social Sciences
(99)
Middle Aged
(82)
Child
(81)
Pediatrics
(81)
Adolescent
(77)
Aged
(60)
Animals
(60)
Psychology
(60)
Public, Environmental & Occupational Health
(57)
Young Adult
(55)
General & Internal Medicine
(52)
Neurosciences & Neurology
(51)
Child, Preschool
(45)
Covid-19
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(27)

Menü

Weitere Dienste

Einstellungen

Frequency of safety net errors in the emergency department: Effect of patient handoffs

Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults

Evaluation of Commercial Milk-Specific Lateral Flow Devices

Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects

Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study

Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men

A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension

Latanoprost Systemic Exposure in Pediatric and Adult Patients with Glaucoma: A Phase 1, Open-Label Study

Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer

New Paths and Policies towards Conflict Prevention: Chinese and Swiss Perspectives

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumors

Oral bioavailability of posaconazole in fasted healthy subjects: Comparison between three regimens and basis for clinical dosage recommendations

What Is in My Patient's Pantry? Addressing Food Insecurity in Primary Care: A Quality Improvement Project

Estrogens, Inflammation, and Cognition: Does Inflammation Mediate Verbal Memory Deficits Observed in Surgically Menopausal Women?

Modulation of 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11βHSD1 Inhibitor

Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity in Vivo Limits Glucocorticoid Exposure to Human Adipose Tissue and Decreases Lipolysis

Novel homozygous likely-pathogenic intronic variant in INS causing permanent neonatal diabetes in siblings

Structural Evolution and Rheology of the Paposo Shear Zone in the Atacama Fault System, Northern Chile

AN EYE FOR AN EYE LEAVES EVERYONE BLIND: FIELDS V. BROWN AND THE CASE FOR KEEPING THE BIBLE OUT OF CAPITAL SENTENCING DELIBERATIONS

Phase 1 Dose-Escalation Study of PF-04449913, An Oral Hedgehog (Hh) Inhibitor, in Patients with Select Hematologic Malignancies

Abstract 4619: PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients

Abstract 906: Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients

Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor

Suchergebnisse filtern